The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...

Here are the top 5 soft tissue sarcoma articles of 2025: ...

Our top 5 highlights from the 2025 San Antonio Breast Cancer Symposium (SABCS) include articles and interviews introducing ...

The 2025 Community Oncology Conference, hosted by COA, reflected a commitment to patient-centered care, access, and ...

To access our top 5 gated pieces of 2025, however, readers must first tell us a little bit about themselves.

Our top HIV content focused primarily on domestic policies, as cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR ...

Panelists discuss how therapy switching is often required to optimize outcomes, especially when adverse effects compromise ...

Exercise improves quality of life and sleep in ovarian cancer patients, with moderate and significant benefits, respectively. Methodological variability and high heterogeneity in trials highlight the ...

Examination of how combination therapy and next-generation immunotherapies are poised to redefine RRMM treatment over the ...

Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...

The approval of subcutaneous amivantamab allows physicians flexibility in offering treatment for non–small cell lung cancer.

The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...